HEPATITIS-C IN THE HEALTH-CARE SETTING .2. SEROPREVALENCE AMONG HEMODIALYSIS STAFF AND PATIENTS IN SUBURBAN NEW-YORK-CITY

被引:18
作者
FORSETER, G
WORMSER, GP
ADLER, S
LEBOVICS, E
CALMANN, M
OBRIEN, TA
机构
[1] Divisions of Infectious Diseases, Nephrology, Gastroenterology, Valhalla, NY
[2] Department of Medicine, New York Medical College, Valhalla, NY
[3] Ortho Diagnostic Systems, Inc., Raritan, NJ
关键词
D O I
10.1016/0196-6553(93)90200-N
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Hepatitis C virus (HCV) is a newly identified blood-borne virus that may pose an occupational hazard for health care workers. Hemodialysis nurses could be anticipated to be at high risk for HCV infection because this group of health care workers frequently comes into contact with blood of a patient population with a seroprevalence rate of at least 10%. Methods: To assess the risk of HCV infection for hemodialysis nurses, serum samples from all of the nurses (22/22, 100%) and patients (125/125, 100%) in one hemodialysis unit (unit A) and 85% (29/34) of nurses from a second unit (unit B), both units in suburban New York City, were tested for HCV antibodies. Samples with positive results of enzyme-linked immunosorbent assay underwent supplemental testing by a first-generation recombinant immunoblot assay. Results: Twenty-four (19%) of the hemodialysis patients in unit A were HCV seropositive. Despite an average of 4.7 years spent working in hemodialysis unit A, none of the nurses tested seropositive for HCV antibody. In unit B, despite an average of 6.4 years working in the unit studied, only one nurse tested seropositive for HCV antibody. This nurse reported a long history of elevated liver function values and a negative HBV core antibody status that predated her hemodialysis nursing career. Conclusions: In contrast to the experience with hepatitis B virus infection, hemodialysis nurses appear to be at low risk for occupationally acquired HCV infection.
引用
收藏
页码:5 / 8
页数:4
相关论文
共 29 条
[1]  
Dienstag, Stevens, Szmuness, The epidemiology of non-A, non-B hepatitis: emerging patterns, Non-A, non-B hepatitis, pp. 119-138, (1981)
[2]  
Garibaldi, Forrest, Bryan, Hanson, Dismukes, Hemodialysis-associated hepatitis, JAMA, 225, pp. 384-389, (1973)
[3]  
Seyckova, Helcl, Walter, Prevalence of viral hepatitis among the hospital staff in CSR between 1980 and 1982, J Hyg Epidemiol Microbiol Immunol, 3, pp. 267-278, (1984)
[4]  
Shusterman, Singer, Infectious hepatitis in dialysis patients, Am J Kidney Dis, 9, pp. 447-455, (1987)
[5]  
Villarejos, Visona, Gutierrez, Rodriguez, Role of saliva, urine and feces in the transmission of type B hepatitis, JAMA, 291, pp. 1375-1378, (1974)
[6]  
Marchesi, Arici, Poletti, Mingardi, Minola, Mecca, Outbreak of non-A, non-B hepatitis in centre hemodialysis patients: a retrospective analysis, Nephrol Dial Transplant, 3, pp. 795-799, (1988)
[7]  
Koretz, Stone, Mousa, Gitnick, The pursuit of hepatitis in dialysis units, Am J Nephrol, 4, pp. 222-226, (1984)
[8]  
Choo, Kuo, Weiner, Et al., Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome, Science, 244, pp. 359-361, (1989)
[9]  
Schlipkoter, Roggendorf, Ernst, Et al., Hepatitis C virus antibodies in hemodialysis patients [Letter], The Lancet, 335, (1990)
[10]  
Tamura, Kobayashi, Kodo, Et al., Hepatitis C virus antibodies in hemodialysis patients [Letter], The Lancet, 335, (1990)